Next-Generation Contraceptives Market - A Global and Regional Analysis: Focus on Gender, Offering, End User, and Region - Analysis and Forecast, 2024-2033

1.1 Trends: Current and Future Impact Assessment
1.2 Supply Chain Overview
1.2.1 Value chain Analysis
1.2.2 Market Map
1.3 R&D Review
1.3.1 Patent Filing Trend by Country, by Company
1.4 Regulatory Landscape
1.5 Market Dynamics Overview
1.5.1 Market Drivers
1.5.2 Market Restraints
1.5.3 Market Opportunities

2.1 Application Segmentation
2.2 Application Summary
2.3 Global Next-Generation Contraceptives Market, by Gender
2.3.1 Male
2.3.2 Female
2.4 Global Next-Generation Contraceptives Market, by End User
2.4.1 Hospital Pharmacies
2.4.2 Retail Pharmacies
2.4.3 Online Channels
2.4.4 Others

3.1 Product Segmentation
3.2 Product Summary
3.3 Global Next-Generation Contraceptives Market, by Offering
3.3.1 Drugs
3.3.1.1 Contraceptive Pills
3.3.1.2 Injectables
3.3.1.3 Patches
3.3.1.4 Others
3.3.2 Devices
3.3.2.1 Condoms
3.3.2.2 Vaginal Rings
3.3.2.3 Intra-uterine Devices
3.3.2.4 Others

4.1 Regional Summary
4.2 Drivers and Restraints as you go along…
4.3 North America
4.3.1 Markets
4.3.1.1 Key Market Participants in North America
4.3.1.2 Business Drivers
4.3.1.3 Business Challenges
4.3.2 North America Next Generation Contraceptives Market, by End User
4.3.3 North America by Country
4.3.3.1 U.S.
4.3.3.2 Canada
4.4 Europe
4.4.1 Markets
4.4.1.1 Key Market Participants in Europe
4.4.1.2 Business Drivers
4.4.1.3 Business Challenges
4.4.2 Europe Next Generation Contraceptives Market, by End User
4.4.3 Europe by Country
4.4.3.1 U.K.
4.4.3.2 Germany
4.4.3.3 France
4.4.3.4 Italy
4.4.3.5 Spain
4.4.3.6 Rest of Europe
4.5 Asia-Pacific
4.5.1 Markets
4.5.1.1 Key Market Participants in Asia-Pacific
4.5.1.2 Business Drivers
4.5.1.3 Business Challenges
4.5.2 Asia-Pacific America Next Generation Contraceptives Market, by End User
4.5.3 Asia-Pacific by Country
4.5.3.1 China
4.5.3.2 Japan
4.5.3.3 India
4.5.3.4 South Korea
4.5.3.5 Rest of Asia-Pacific
4.6 Latin America
4.6.1 Markets
4.6.1.1 Key Market Participants in Latin America
4.6.1.2 Business Drivers
4.6.1.3 Business Challenges
4.6.2 Latin America Next Generation Contraceptives Market, by End User
4.6.3 Latin America by Country
4.6.3.1 Brazil
4.6.3.2 Mexico
4.6.3.3 Rest of Latin America
4.7 Middle East and Africa
4.7.1 Markets
4.7.1.1 Key Market Participants in Middle East and Africa
4.7.1.2 Business Drivers
4.7.1.3 Business Challenges
4.7.2 Middle East and Africa Next Generation Contraceptives Market, by End User

5.1 Competitive Landscape
5.2 Company Profiles
5.2.1 AbbVie
5.2.1.1 Company Overview
5.2.1.2 Top Products / Product Portfolio
5.2.1.3 Top Competitors
5.2.1.4 Target Customers /End-Users
5.2.1.5 Key Personnel
5.2.1.6 Analyst View
5.2.2 Bayer Corporation
5.2.2.1 Company Overview
5.2.2.2 Top Products / Product Portfolio
5.2.2.3 Top Competitors
5.2.2.4 Target Customers /End-Users
5.2.2.5 Key Personnel
5.2.2.6 Analyst View
5.2.3 Cooper Surgical, Inc.
5.2.3.1 Company Overview
5.2.3.2 Top Products / Product Portfolio
5.2.3.3 Top Competitors
5.2.3.4 Target Customers /End-Users
5.2.3.5 Key Personnel
5.2.3.6 Analyst View
5.2.4 Church & Dwight Co, Inc.
5.2.4.1 Company Overview
5.2.4.2 Top Products / Product Portfolio
5.2.4.3 Top Competitors
5.2.4.4 Target Customers /End-Users
5.2.4.5 Key Personnel
5.2.4.6 Analyst View
5.2.5 Merck & Co Inc.
5.2.5.1 Company Overview
5.2.5.2 Top Products / Product Portfolio
5.2.5.3 Top Competitors
5.2.5.4 Target Customers /End-Users
5.2.5.5 Key Personnel
5.2.5.6 Analyst View
5.2.6 Pfizer
5.2.6.1 Company Overview
5.2.6.2 Top Products / Product Portfolio
5.2.6.3 Top Competitors
5.2.6.4 Target Customers /End-Users
5.2.6.5 Key Personnel
5.2.6.6 Analyst View
5.2.7 Reckitt Benckiser Group Plc
5.2.7.1 Company Overview
5.2.7.2 Top Products / Product Portfolio
5.2.7.3 Top Competitors
5.2.7.4 Target Customers /End-Users
5.2.7.5 Key Personnel
5.2.7.6 Analyst View
5.2.8 Teva Pharmaceuticals Industries Ltd.
5.2.8.1 Company Overview
5.2.8.2 Top Products / Product Portfolio
5.2.8.3 Top Competitors
5.2.8.4 Target Customers /End-Users
5.2.8.5 Key Personnel
5.2.8.6 Analyst View
5.2.9 The Female Health Company/Veru Inc.
5.2.9.1 Company Overview
5.2.9.2 Top Products / Product Portfolio
5.2.9.3 Top Competitors
5.2.9.4 Target Customers /End-Users
5.2.9.5 Key Personnel
5.2.9.6 Analyst View
5.2.10 Afaxys, Inc
5.2.10.1 Company Overview
5.2.10.2 Top Products / Product Portfolio
5.2.10.3 Top Competitors
5.2.10.4 Target Customers /End-Users
5.2.10.5 Key Personnel
5.2.10.6 Analyst View
5.2.11 Aditxt
5.2.11.1 Company Overview
5.2.11.2 Top Products / Product Portfolio
5.2.11.3 Top Competitors
5.2.11.4 Target Customers /End-Users
5.2.11.5 Key Personnel
5.2.11.6 Analyst View
5.2.12 Daré Bioscience, Inc
5.2.12.1 Company Overview
5.2.12.2 Top Products / Product Portfolio
5.2.12.3 Top Competitors
5.2.12.4 Target Customers /End-Users
5.2.12.5 Key Personnel
5.2.12.6 Analyst View
5.2.13 TherapeuticsMD, Inc
5.2.13.1 Company Overview
5.2.13.2 Top Products / Product Portfolio
5.2.13.3 Top Competitors
5.2.13.4 Target Customers /End-Users
5.2.13.5 Key Personnel
5.2.13.6 Analyst View
5.2.14 Other Companies